Regenerx Biopharm In (RGRX)

Currency in USD
0.0002
-0.0048(-96.00%)
Closed·
RGRX Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week Low
Fair Value
Day's Range
0.00020.0002
52 wk Range
0.00020.0733
Key Statistics
Prev. Close
0.0002
Open
0.0002
Day's Range
0.0002-0.0002
52 wk Range
0.0002-0.0733
Volume
243
Average Volume (3m)
303
1-Year Change
-85.71%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RGRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Regenerx Biopharm In News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Regenerx Biopharm In Company Profile

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for the treatment of dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee’s Pharmaceutical Group and HLB Therapeutics. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.

Compare RGRX to Peers and Sector

Metrics to compare
RGRX
Peers
Sector
Relationship
P/E Ratio
0.0x−3.5x−0.5x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x2.3x2.6x
Price / LTM Sales
0.0x10.3x3.3x
Upside (Analyst Target)
0.0%190.7%43.5%
Fair Value Upside
Unlock1.8%6.3%Unlock

Earnings

Latest Release
Nov 10, 2023
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

RGRX Income Statement

FAQ

What Stock Exchange Does Regenerx Biopharm In Trade On?

Regenerx Biopharm In is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Regenerx Biopharm In?

The stock symbol for Regenerx Biopharm In is "RGRX."

What Is the Regenerx Biopharm In Market Cap?

As of today, Regenerx Biopharm In market cap is 301.00.

What Is Regenerx Biopharm In's Earnings Per Share (TTM)?

The Regenerx Biopharm In EPS (TTM) is -1.18.

From a Technical Analysis Perspective, Is RGRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Regenerx Biopharm In Stock Split?

Regenerx Biopharm In has split 1 times.

How Many Employees Does Regenerx Biopharm In Have?

Regenerx Biopharm In has 3 employees.

What is the current trading status of Regenerx Biopharm In (RGRX)?

As of 05 Aug 2025, Regenerx Biopharm In (RGRX) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.07.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.